Tariffs, Taxes, and a Rate Hike Warning

🔔 After the Bell

🎯 Session Review

Friday wrapped up with a mild but meaningful pullback across all three major indexes. The S&P 500 slipped 0.05% to 7,353.96, the Nasdaq dropped 0.24% to 25,297.62, and the Dow shed 44 points to close at 51,876.11. Not a dramatic sell-off, but the kind of slow bleed that tells you investors are quietly repricing risk.

The headline noise was loud even if the moves were small. Trump threatened 100% tariffs on any country that imposes a digital services tax on U.S. companies, and the EU fired back almost immediately, saying it has the sovereign right to regulate economic activity. That kind of tit-for-tat language tends to make traders nervous, and today was no exception.

Treasury yields offered a small consolation. The 10-year dipped to 4.37% and the 5-year fell to 4.13%, suggesting some flight to safety. The dollar index also slipped to 101.32, which gave a modest lift to risk assets abroad but wasn't enough to stop the bleeding at home.

Elon Just Spent $60 Billion of SpaceX Stock on What!??! [ad]

📊 Today's Market Movers

▲ Gainers SLS ▲ +17.66% LCID ▲ +15.63% MRNA ▲ +12.59% CCC ▲ +11.58% IBRX ▲ +11.81%

▼ Losers MAAS ▼ -26.82% ON ▼ -23.66% BE ▼ -18.13% RGC ▼ -13.48% WDC ▼ -13.17%

🚀 Key Catalysts

The biggest macro gut punch of the day came from Minneapolis Fed President Neel Kashkari, who said he now expects one interest rate hike this year. That is a significant pivot. Markets had been quietly hoping the Fed's next move would be a cut, not a hike. Kashkari's comments reignited concerns that the inflation fight isn't over, and that higher-for-longer just got a new meaning.

On the bright side, Moderna (MRNA) was the clear standout, surging over 12% and leading the S&P 500 after unveiling a new cell therapy program. It's now tracking toward its highest close since late 2024. ImmunityBio (IBRX) also caught a wave of biotech enthusiasm, climbing over 11%. Health and biotech gave investors at least one corner of the market to feel good about today.

Verizon (VZ) made a big spectrum play, successfully bidding nearly 3.2 billion dollars in an FCC auction for mid-band wireless licenses. That's a meaningful long-term infrastructure investment, though it adds to the company's already substantial debt load. Investors will be watching how VZ plans to fund the purchase without squeezing its dividend.

SpaceX is offering you shares. Don't take them. [ad]

Wall Street's Favorite AI Stocks Are Walking Into a MASSACRE

🎭 Investor Mood

Today's mood was best described as cautious but not panicked. The tariff threats between the U.S. and EU are familiar territory at this point, but the specific threat of 100% tariffs tied to digital services taxes puts a new target on tech-heavy economies like France and the UK. For investors with international exposure, that's worth watching closely.

Consumer sentiment did offer a small silver lining. The University of Michigan's June survey showed improvement from recent record lows, with easing gas prices cited as the main driver. It's not a roaring comeback in confidence, but any upward tick matters when sentiment has been in the basement.

Bitcoin slipped slightly to 59,650, reflecting the broader risk-off vibe without any dramatic collapse. The crypto market is essentially mirroring equity hesitation right now, waiting for a clearer macro signal before committing to a direction.

Former White House Insider Predicts New Gold Surge [ad]

🔍 5 Focus Points for Tomorrow

🏛️	Watch for Fed officials responding to Kashkari's rate hike call. Any agreement could reset rate expectations sharply.

🌍	Monitor EU and U.S. trade rhetoric over digital services taxes. Escalation risk is real and growing.

🤖	Biotech sector momentum: Moderna and ImmunityBio both surged. Watch for follow-through or profit-taking early next week.

🏛️	Treasury yields ticked lower today. A continued drop would signal markets are pricing in slower growth despite Kashkari's hawkish lean.

📊	Verizon's 3.2 billion spectrum bid adds to debt load. Watch analyst reactions and any credit rating commentary next week.

SpaceX 'Dark Energy' Replaces Foreign Oil

💸 Bottom Line

The Kashkari rate hike comment is the story investors should be sitting with this weekend. If even one Fed official is now talking hikes instead of cuts, the interest rate narrative just got a lot more complicated. Watch for other Fed speakers in the coming weeks to either reinforce or push back on that view.

The EU-U.S. digital tax standoff is also worth monitoring. If Trump follows through with 100% tariffs on digital-tax countries, the blowback could hit U.S. tech companies operating in Europe just as hard as it hits foreign firms. Companies like Alphabet, Meta, and Apple have enormous European revenue exposure.

Finally, keep an eye on the biotech sector. Moderna's cell therapy announcement is a reminder that innovation can still move stocks in a big way, regardless of the macro backdrop. With MRNA surging and IBRX catching a ride, biotech momentum could build into next week if more pipeline news surfaces.

SpaceX IPO… the crypto play nobody sees [ad]